Detalles de la búsqueda
1.
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients.
Blood
; 139(16): 2499-2511, 2022 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34995350
2.
Venetoclax ramp-up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study.
Br J Haematol
; 202(1): 48-53, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951278
3.
Advances in treatment of elderly primary central nervous system lymphoma.
Br J Haematol
; 196(3): 473-487, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34448202
4.
Rare central nervous system lymphomas.
Br J Haematol
; 197(6): 662-678, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292959
5.
Population-based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large-cell lymphoma using Public Health England data.
Br J Haematol
; 196(4): 932-938, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34664265
6.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32688395
7.
Improved survival outcomes despite older age at diagnosis: an era-by-era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom.
Br J Haematol
; 195(4): 561-570, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34368948
8.
Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.
Br J Haematol
; 194(2): 365-377, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959947
9.
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression.
Br J Haematol
; 189(6): 1064-1073, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32130737
10.
Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice.
Br J Haematol
; 189(5): 879-887, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31997308
11.
Outcomes of older patients with primary central nervous system lymphoma treated in routine clinical practice in the UK: methotrexate dose intensity correlates with response and survival.
Br J Haematol
; 190(3): 394-404, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32232989
12.
Kinetics of T-cell subset reconstitution following treatment with bendamustine and rituximab for low-grade lymphoproliferative disease: a population-based analysis.
Br J Haematol
; 184(6): 957-968, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548597
13.
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.
Br J Haematol
; 187(2): 185-194, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31222719
14.
Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated.
Haematologica
; 104(8): 1572-1579, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30655376
15.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297826
16.
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma.
Haematologica
; 108(3): 882-888, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36300776
17.
Management of cardiovascular complications of bruton tyrosine kinase inhibitors.
Br J Haematol
; 196(1): 70-78, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34498258
18.
Guideline for the treatment of chronic lymphocytic leukaemia.
Br J Haematol
; 197(5): 544-557, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313007
19.
First-line use of rituximab correlates with increased overall survival in late post-transplant lymphoproliferative disorders: retrospective, single-centre study.
Eur J Haematol
; 98(1): 38-43, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27232286
20.
Extended follow-up of CD4+ T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine.
Hematol Oncol
; 39(1): 137-140, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32860715